Carbamazepine

Carbamazepine

Carbamazepine (Tegretol, Neurotop)

Mechanism of action

Anticonvulsant; Mood stabiliser.

Mechanism of action still not fully understood. 

Binds to voltage-dependent sodium channels and lowers the nerve response and high frequency repetitive firing of neurons. Decrease of action potential in the nucleus ventralis thalami and inhibition of the lingual mandibular reflex were also observed. 

Mood stabilising effect is caused probably by increased GABA transmission and dopamine turnover. 

Indications and dose

Pharmacokinetics

Onset of action

  • peak-plasma concentration: 6–8 hours
  • steady-state: within 1–2 weeks

Half-life of elimination: 36 hours, shortens to 12 hours over time

Metabolism: Hepatic

Elimination: Kidneys (72 %), faeces (28 %)

Directions for administration 

Oral suspension should be shaken before use.

Medicinal forms

Tablets – 100 mg, 200 mg, 400 mg

Oral suspension – 100 mg/5 ml

Side-effects

CNS: dizziness, blurred vision, muscle twitch, unconsciousness, respiratory arrest

CVS: decreased cardiac output, heart block, hypotension, bradycardia, ventricular arrhythmias, cardiac arrest

Nystagmus, diplopia

Ataxia

Benign leukopenia

Skin rash

Stevens-Johnson syndrome

Hyponatraemia

Hepatic dysfunction

References

  1. Pharm 101: Carbamazepine • LITFL
  2. Carbamazepine: Uses, Interactions, Mechanism of Action | DrugBank Online
  3. https://www.medicines.org.uk/emc/search?q=carbamazepine